ICU Medical, Inc.

ICU Medical, Inc.

ICUI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.1B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ICU Medical, Inc.ICU Medical, Inc.136.5-2%1.90.6
$192.25

Target Price by Analysts

18.4% upsideICU Medical Target Price DetailsTarget Price
$153.27

Current Fair Value

5.6% downside

Overvalued by 5.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.10 Billion
Enterprise Value$5.04 Billion
Earnings per Share$0.03
Beta0.76
Outstanding Shares25,000,000

Return

Return on Equity1.78%ROE
Return on Assets0.96%
Return on Invested Capital2.15%

Valuation & Multiples

P/E Ratio136.48P/E Ratio
PEG-296.78PEG
Price to Sales1.89Price to Sales
Price to Book Ratio1.89Price to Book Ratio
Enterprise Value to Revenue2.33
Enterprise Value to EBIT67.48
Enterprise Value to Net Income131
Total Debt to Enterprise0.25
Debt to Equity0.58Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$1.91
Consensus analyst estimate
Revenue Estimate
$533.44 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.14
Consensus analyst estimate
Revenue Estimate
$552.07 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 22.16%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.26%▼ 103.26%
Total Invested$90.75M▼ 97.65%
Investors Holding77▼ 218.00%

About ICU Medical, Inc.

9,000 employees
CEO: Vivek Jain

ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...

ICU Medical Insider Information FAQ

Stockcircle tracks 5 top investors with a current 13F position in ICU Medical. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 10 open-market insider sales for ICU Medical in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.